Fingolimod After a First Unilateral Episode of Acute Optic Neuritis (MOVING) – Preliminary Results From a Randomized, Rater-Blind, Active-Controlled, Phase 2 Trial

BMC Neurology - United Kingdom
doi 10.1186/s12883-020-01645-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phenytoin for Neuroprotection in Patients With Acute Optic Neuritis: A Randomised, Placebo-Controlled, Phase 2 Trial

The Lancet Neurology
Neurology
2016English

Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-Controlled, Phase 2 Trial

The Lancet Neurology
Neurology
2017English

Oral Lipoic Acid as a Treatment for Acute Optic Neuritis: A Blinded, Placebo Controlled Randomized Trial

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2019English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology
Neurology
2015English

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Individualized Metacognitive Therapy for Delusions: A Randomized Controlled Rater-Blind Study

Journal of Behavior Therapy and Experimental Psychiatry
ArtsHumanitiesClinical PsychologyCognitive PsychologyMental HealthPsychiatryExperimental
2017English

Project SUCCESS: Results From a Randomized Controlled Trial

ISRN Public Health
2012English

Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Accidental Exposures to Peanut and Other Food Allergens: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy